Diclacare® 2.5 mg/ml is the new oral suspension for lambs and calves based on diclazuril from the Alivira group.
Diclacare® 2.5 mg/ml is authorized for the prevention of clinical signs of coccidiosis caused by Eimeria crandallis and Eimeria ovinoidalis in lambs, and Eimeria bovis and Eimeria zuernii in calves.
When administered before the onset of symptoms, preventive treatment aimed at animals in the early stages of the infectious cycle significantly reduces the severity of the disease and oocyst production, as well as improving weight gain. It is given orally in a single dose of 1 ml per 2.5 kg of body weight.
Available in 1- and 2.5-liter containers, Diclacare® 2.5 mg/ml is being launched in several European Union countries, including Spain, Portugal, Italy, Ireland, and Greece.
